Latest Asx Companies News

Page 10 of 12
McMillan Shakespeare Limited reported a 14.1% rise in statutory net profit for FY25, marking the completion of its transformative Simply Stronger program that enhanced digital offerings and customer reach.
Claire Turing
Claire Turing
28 Aug 2025
BetMakers Technology Group has completed a major transformation in FY25, delivering positive adjusted EBITDA and strong operating cash flow while expanding its global footprint with a strategic US acquisition.
Sophie Babbage
Sophie Babbage
28 Aug 2025
ClearView Wealth Limited reported strong second-half growth in FY25, with underlying NPAT up 11% and life insurance margins rebounding. The company is poised for further expansion in FY26, backed by technology upgrades and strategic simplification.
Victor Sage
Victor Sage
28 Aug 2025
InvestSMART Group has showcased its position as Australia’s leading direct-to-investor digital wealth platform, reporting $711 million in funds under management and highlighting its integrated ecosystem of low-cost funds, research, and tools.
Claire Turing
Claire Turing
27 Aug 2025
Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.
Ada Torres
Ada Torres
20 Aug 2025
Sandon Capital Investments reports a robust 72% increase in net profits, driven by a 32.2% portfolio return that more than doubles market performance, alongside a healthy fully franked dividend yield.
Victor Sage
Victor Sage
19 Aug 2025
Star Minerals Limited addresses a sharp rise in its share price and trading volume, attributing the movement to pending assay results from recent drilling activities. The company confirms compliance with ASX disclosure rules while preparing to release interpreted data.
Maxwell Dee
Maxwell Dee
19 Aug 2025
Lumos Diagnostics has submitted its CLIA waiver application for FebriDx® to the FDA, backed by strong clinical data and triggering significant milestone payments. Approval could expand the U.S. market opportunity fifteen-fold to over $1 billion.
Ada Torres
Ada Torres
18 Aug 2025
Miramar Resources has extended its Share Purchase Plan closing date to 27 August 2025, giving shareholders more time to invest at a 20% discount as the company awaits critical exploration results.
Maxwell Dee
Maxwell Dee
15 Aug 2025
Rhythm Biosciences has responded to an ASX price query following a sudden surge in its share price and trading volume, confirming no undisclosed information is driving the activity.
Ada Torres
Ada Torres
6 Aug 2025
Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.
Ada Torres
Ada Torres
6 Aug 2025
RBR Group stands uniquely positioned as the only ASX-listed company directly linked to Mozambique’s LNG megaprojects, gearing up for a sector revival and broader African growth.
Maxwell Dee
Maxwell Dee
21 July 2025

Browse the archive

Full archive